| Name | Title | Contact Details |
|---|
Formativ Health is a management services organization that is redefining Practice Management and end-to-end Revenue Cycle through the integration of technology-enabled Patient Access, Revenue Cycle Management, Practice Operations and Advisory Services. At Formativ Health our approach is simple: We seek to understand your strategy and business goals so that we can define solutions tailored to your needs and designed to maximize performance. As the health care industry continues to transform, we partner with providers to successfully improve their financial health, adapt to changing risk-based payment models, increase physician productivity and satisfaction, and enhance the patient experience. Our technology-enabled services are designed to provide flexibility across the full continuum of Practice Management and Revenue Cycle
Health Management Associates is a for-profit corporation which operates hospitals and other health care facilities in the southern United States. It is headquartered at 5811 Pelican Bay Blvd. in North Naples, Florida. Its current CEO is Gary D. Newsome. Serving on the board of directors are William Schoen, Pascal Goldschmidt, Donald Kiernan, William Steere, Vicki O'Meara, Robert Knox, Kent Dauten and Randolph W. Westerfield. Health Management Associates (HMA) is an organization that provides people, processes, capital, and subject matter expertise to hospitals and physician practices per their individual needs or governing requirements (1). Additional functions that HMA provides to hospitals and provider groups are to invest capital for renewal of hospital facilities, recruiting of physicians to expand community resources or hospital services, and promote the use standardized best practices throughout HMA facilities.
Experienced Chiropractors located in Westlake & Ohio City, OH. Our services include Chiropractic care, Massage, and Acupuncture.
SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.
West Public Health Center is a Wheaton, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.